SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-22-000544
Filing Date
2022-09-07
Accepted
2022-09-07 17:28:00
Documents
1
Group Members
ALI BEHBAHANIANTHONY A. FLORENCE, JR.CARMEN CHANGEDWARD T. MATHERSFOREST BASKETTGROWTH EQUITY OPPORTUNITIES 17, LLCLIZA LANDSMANMOHAMAD H. MAKHZOUMINEA 15 GP, LLCNEA 17 GP, LLCNEA PARTNERS 15, L.P.NEA PARTNERS 17, L.P.NEW ENTERPRISE ASSOCIATES 15, L.P.NEW

Document Format Files

Seq Description Document Type Size
1 GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# geoiv-verona_18650.htm SC 13D/A 632845
  Complete submission text file 0001072613-22-000544.txt   635106
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities Fund IV, LLC (Filed by) CIK: 0001644965 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Subject) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89843 | Film No.: 221231985
SIC: 2834 Pharmaceutical Preparations